| PMID | Title | Journal | Publication Year | Author | View in RVdb |
|---|---|---|---|---|---|
| 27119620 | Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats. | Acta Physiol (Oxf) | 2016 | Tanajak P;Sa-Nguanmoo P;Wang X;Liang G;Li X;Jiang C;Chattipakorn SC;Chattipakorn N | View More |
| 28391633 | Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats. | Cardiovasc Ther | 2017 | Tanajak P;Sa-Nguanmoo P;Apaijai N;Wang X;Liang G;Li X;Jiang C;Chattipakorn SC;Chattipakorn N | View More |